Silence Therapeutics PLC

NAS:SLNHealthcareNASDAQ:NBInasdaq_composite

$19.58+125.58%At closeAt close · Tue 20 Oct · ≈ AED 71.91 · Market cap $539.5M · Next earnings Thu 5 Nov · Extended $19.58 +0.00%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	31.3%	39.9%	37.8%	59.3%	72.7%	61.5%	—	—
Operating margin	−654.3%	−369.0%	−281.9%	−195.5%	−146.4%	−16,056.0%	−16,056.0%	+0.0 pts
Net margin	−594.0%	−317.4%	−232.4%	−170.5%	−104.7%	−15,851.9%	−15,851.9%	+0.0 pts
EBITDA margin	−648.5%	−365.9%	−226.2%	−196.2%	−113.2%	−15,750.6%	—	—
Return on equity	−359.3%	−462.2%	−185.9%	−196.7%	−42.3%	−142.2%	−142.2%	+0.0 pts
Return on assets	−37.9%	−41.0%	−38.2%	−36.2%	−28.0%	−67.4%	−67.4%	+0.0 pts
Return on capital employed	−59.4%	−56.5%	−58.2%	−51.1%	−42.6%	−76.2%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.4%	0.1%	0.4%	0.3%	0.1%	0.1%	—	—
Interest coverage	−2,240.4×	−5,726.8×	−1,058.7×	−1,458.9×	0.0×	0.0×	—	—
Current ratio	3.0×	5.7×	4.4×	4.6×	11.1×	8.7×	8.7×	+0.0%
Quick ratio	3.0×	5.7×	4.4×	4.6×	11.1×	8.7×	—	—
Cash ratio	1.1×	4.8×	2.5×	3.1×	7.2×	0.8×	0.8×	+0.0%
Asset turnover	0.1×	0.1×	0.2×	0.2×	0.3×	0.0×	—	—
Receivables turnover	0.2×	37.5×	19.3×	1.1×	2.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—